Toxicology Podcasts This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Surviving childhood cancer treatment
In a British cohort, 30% of patients who had survived childhood cancer had died within 45 years of diagnosis; only 6% were expected to have died. 51% had developed a new primary cancer, but a 26% died of cardiovascular disease - thought to be caused by their treatment. Consequently, efforts to reduce long term mortality have focused on reducing exposure to the most toxic aspects of anticancer treatment, including radiotherapy. In this pod cast we’re joined by Daniel Mulrooney, associate professor in the Division of Cancer Survivorship, at St Jude Children’s Research Hospital and one of the authors of the paper Major...
Source: The BMJ Podcast - January 21, 2020 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts

Surviving childhood cancer treatment
In a British cohort, 30% of patients who had survived childhood cancer had died within 45 years of diagnosis; only 6% were expected to have died. 51% had developed a new primary cancer, but a 26% died of cardiovascular disease - thought to be caused by their treatment. Consequently, efforts to reduce long term mortality have focused on reducing exposure to the most toxic aspects of anticancer treatment, including radiotherapy. In this podcast we’re joined by Daniel Mulrooney, associate professor in the Division of Cancer Survivorship, at St Jude Children’s Research Hospital and one of the authors of the paper Major ...
Source: The BMJ Podcast - January 21, 2020 Category: General Medicine Authors: BMJ Group Source Type: podcasts

Getting bisphenol A out of food containers, and tracing minute chemical mixtures in the environment
As part of a special issue on chemicals for tomorrow ’s Earth, we’ve got two green chemistry stories. First, host Sarah Crespi talks with contributing correspondent Warren Cornwell about how a company came up with a replacement for the popular can lining material bisphenol A and then recruited knowledgeable critics to test its safety. Sarah is a lso joined by Beate Escher of the Helmholtz Centre for Environmental Research and the University of Tübingen to discuss ways to trace complex mixtures of humanmade chemicals in the environment. They talk about how new technologies can help detect these mixtures, understand t...
Source: Science Magazine Podcast - January 16, 2020 Category: Science Authors: Science Tags: Scientific Community Source Type: podcasts

Alternate Dosing For Immunotherapy
John Freuhauf, M.D., PhD, discusse Lowering Toxicity through alternate dosing. Author: Annual-Meeting Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts

Could Clinicians Change The Way They Treat Patients
John Freuhauf, M.D., PhD, discusses toxic therapy and how it could change. Author: Annual-Meeting Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts

Fixing Toxic Therapy
Addressing toxity that causes colitis. Author: Annual-Meeting Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts

08 August 2019: A mindset for success, and mercury in fish
This week, a mindset to improve school performance, and the complex story of how mercury accumulates in fish.In this episode:00:46 Growth MindsetHow a one hour course could improve academic achievement. Research article: Yeager et al.11:47 Research HighlightsAn extinct giant parrot, and hacking Manhattan’s traffic. Research Highlight: Polly wants many crackers: fossils reveal first known giant parrot; Research Article: Vivek et al.13:42 Toxic TunaMethylmercury levels in fish may increase due to climate change and overfishing, despite declines in emissions. Research Article: Sc...
Source: Nature Podcast - August 7, 2019 Category: Science Authors: Springer Nature Limited Source Type: podcasts

Emerging Data For Personalized Vaccine Approach: Safety Profile Was Clean & No Dose Limiting Toxicities, Reached 1mg Dose, Moving Into A Phase 2 Study
Tal Zaks MD, PhD, Chief Medical Officer at Moderna Therapeutics Discusses Emerging Data For Personalized Vaccine Approach: Safety Profile Was Clean & No Dose Limiting Toxicities, Reached 1mg Dose, Mov... Author: Annual-Meeting Added: 06/07/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 7, 2019 Category: Cancer & Oncology Source Type: podcasts

Caring For Every Patient And Learning From Every Patient
Yousuf Zafar, MD, discusses the importance of patient care. Financial barriers to clinical trial enrollment are an area of active investigation. Financial toxicity as a concept describes how high c... Author: Annual-Meeting Added: 06/07/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 7, 2019 Category: Cancer & Oncology Source Type: podcasts

The Quality and Completeness of Data
Yousuf Zafar, MD, discusses the importance of questioning the qaulity and completenesss of Data. Financial barriers to clinical trial enrollment are an area of active investigation. Financial toxicit... Author: Annual-Meeting Added: 06/07/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 7, 2019 Category: Cancer & Oncology Source Type: podcasts

Financial Toxicity and Equitable Access to Clinical Trials
 Yousuf Zafar, MD, discuses the role of Real World Evidence in cancer care. Financial barriers to clinical trial enrollment are an area of active investigation. Financial toxicity as a concept descr... Author: Annual-Meeting Added: 06/07/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 7, 2019 Category: Cancer & Oncology Source Type: podcasts

Toxicity Of Nivolumab & Ipilimumab: Were Still Learning How To Leverage These Treatments In The Pre-Operative Setting
Tina Cascone MD Of The University of Texas MD Anderson Cancer Center Discusses Toxicity Of Nivolumab & Ipilimumab: Were Still Learning How To Leverage These Treatments In The Pre-Operative Setting. ... Author: Annual-Meeting Added: 06/06/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 6, 2019 Category: Cancer & Oncology Source Type: podcasts

Updates In Esophageal & Gastric Cancers: When Dose Of Xeloda & Oxaliplatin Is Reduced In Frail Patients They Did Very Well & Had Less Toxicity
Nicholas Rohs MD @NickRohsMD Of Mount Sinai Discusses Updates In Esophageal & Gastric Cancers: When Dose Of Xeloda & Oxaliplatin Is Reduced In Frail Patients They Did Very Well & Had Less Toxicity. Author: Annual-Meeting Added: 06/04/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 4, 2019 Category: Cancer & Oncology Source Type: podcasts

Cancer & Finances: Development Of A Financial Navigation Program To Ease The Burden Of Financial Toxicity
Melissa Monak CPC Of Cleveland Clinic Discusses Cancer & Finances: Development Of A Financial Navigation Program To Ease The Burden Of Financial Toxicity. Author: Annual-Meeting Added: 06/02/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 3, 2019 Category: Cancer & Oncology Source Type: podcasts